![Joshua Reed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joshua Reed
Direttore Finanziario/CFO presso
ALKERMES PLC
Patrimonio netto: 599 653 $ in data 31/07/2026
Profilo
Mr. Joshua Reed is a Chief Financial Officer & Senior Vice President at Alkermes Plc and an Independent Director at Scholar Rock Holding Corp.
He is on the Board of Directors at Scholar Rock Holding Corp.
Mr. Reed was previously employed as a Chief Financial & Accounting Officer by Omega Therapeutics, Inc., a Chief Financial Officer & Treasurer by Aldeyra Therapeutics, Inc., a Vice President & Head-Finance Operations by Bristol Myers Squibb Co., and a Vice President-Strategic Business Development by JPMorgan Chase & Co. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Stephen M.
Ross School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/07/2026 | 12.679 ( 0,01% ) | 599 653 $ | 31/07/2026 |
Posizioni attive di Joshua Reed
| Società | Posizione | Inizio |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Direttore/Membro del Consiglio | 18/03/2021 |
| ALKERMES PLC | Direttore Finanziario/CFO | 15/09/2025 |
Precedenti posizioni note di Joshua Reed
| Società | Posizione | Fine |
|---|---|---|
| OMEA THER | Direttore Finanziario/CFO | 31/05/2024 |
| ALDEYRA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 10/05/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/07/2018 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01/01/2005 |
Formazione di Joshua Reed
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
